Temporal Change in Parasternal Thickening Fraction as a Predictor for Weaning
Launched by CAIRO UNIVERSITY · Jul 16, 2025
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help doctors decide the best time to take patients off mechanical ventilation—a machine that helps people breathe when they can’t do so on their own. The study looks at how changes in a specific muscle near the chest (measured using ultrasound) might predict if a patient is ready to breathe independently without the machine. Finding the right time to stop mechanical ventilation is very important because removing it too early or too late can cause serious problems.
People who might join this study are adults who have been on a breathing machine for at least 24 hours and are considered ready to start the process of weaning off it. However, people who have had a tracheostomy (a breathing tube inserted into the neck), have certain muscle diseases, or if ultrasound images can’t be taken properly won’t be able to participate. If you join, you can expect to have ultrasound exams to check the chest muscle over time as doctors decide when to remove the breathing machine. This study is not yet recruiting participants but aims to improve safety and outcomes for patients who need help breathing.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Mechanically ventilated for 24 hours or more ready for weaning
- Exclusion Criteria:
- • Refusal Tracheostomized Inability to obtain ultrasound views patients with neuromuscular disease
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Cairo Governorate, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported